MEND Adopted by Geisinger to Enhance Patient Care

Clinical nutrition to enhance healing, recovery and outcomes from joint replacement surgery.

NEW YORK - October 8, 2019 - ( )

MEND, a clinical nutrition company located in BioLabs@NYULangone in New York City, announced today that it has been added to Geisinger’s formulary. The product, MEND Joint Replacement ( ), crosses a very high bar for scientific efficacy and operational review by a leader in value-based care and will be integrated into standard of care for all joint replacement patients. All Rights Reserved.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.